|
⚲
|
| Keyboard |
| Aguiar-Lucander Renee
✚
|
|
|---|---|
| CIK # | 0001591617 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001591617] | |
| 4 | [0001591617] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| AC Immune SA | |
| Aguiar-Lucander Renee | |
| Zyla Life Sciences |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Option exercise | 60,000 | $0.00 | |
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Conversion | 171,241 | $6.00 | 1,027,446 |
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Buy | 83,333 | $12.00 | 999,996 |
|
Zyla Life Sciences EGLT
Senior Convertible Debt · derivative
|
2014-02-11 | Conversion | $0.00 | ||
|
Zyla Life Sciences EGLT
Warrants · derivative
|
2014-02-11 | Option exercise | 60,000 | $0.00 |